Rona Silkiss
Chief Resident, PGY-3
Credentials: · ·
History
2024–PresentPGY-32024–Present
- 2027–2029
Ophthalmic Plastic and Reconstructive Surgery
- 2023–2024
1976–1980
Research
Vismodegib for periocular and orbital basal cell carcinoma
JAMA Ophthalmology · 2013 · Last of 5 authors · 69 citations
Rituximab for thyroid eye disease
Ophthalmic Plastic and Reconstructive Surgery · 2010 · First of 4 authors · Corresponding · 58 citations
Case report · American Journal of Ophthalmology Case Reports · 2020 · Last of 4 authors · Corresponding · 47 citations
- MW
6 papers · 2 as a resident
- HB
5 papers
5 papers · 2 as a fellow
- SL
4 papers
- EM
3 papers
- SB
3 papers · 3 as a resident
3 papers · 2 as a resident
- AG
2 papers · 1 as a resident
Clinical trials
- 2006–2009
Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy
Principal investigator · Completed · Phase 1, Phase 2
Silkiss, Rona Z., M.D., FACS